BACKGROUND: To evaluate the feasibility of 3D CT enterography using oral gastrografin in patients with small bowel obstruction (SBO), focusing on improving diagnostic performance as compared with the use of axial CT imagings and fluoroscopic findings. MATERIAL AND METHODS: For a 10-month period, 18 patients with known SBO detected clinically and radiologically were enrolled. In all patients, gastrografin was ingested prior to CT enterography. Twelve patients underwent a fluoroscopic examination. Images were randomly assessed for confidence for the level, for the cause of SBO, and for the assessment of the interpretability of each image by two gastrointestinal radiologists. The results were considered statistically significant using the Wilcoxon rank sum test. RESULTS: All patients (100%) well tolerated the administration of oral gastrografin. The use of 3D CT enterography significantly improved diagnostic confidence for the interpretation of the level, cause of SBO, and the assessment of the interpretability of each image as compared with the use of axial CT images (P < 0.05). 3D CT enterography was superior as compared to fluoroscopic examination (P < 0.05). CONCLUSION: The use of gastrografin for 3D CT enterography is a safe and feasible technique for precise evaluation of known or suspected SBO.
BACKGROUND: To evaluate the feasibility of 3D CT enterography using oral gastrografin in patients with small bowel obstruction (SBO), focusing on improving diagnostic performance as compared with the use of axial CT imagings and fluoroscopic findings. MATERIAL AND METHODS: For a 10-month period, 18 patients with known SBO detected clinically and radiologically were enrolled. In all patients, gastrografin was ingested prior to CT enterography. Twelve patients underwent a fluoroscopic examination. Images were randomly assessed for confidence for the level, for the cause of SBO, and for the assessment of the interpretability of each image by two gastrointestinal radiologists. The results were considered statistically significant using the Wilcoxon rank sum test. RESULTS: All patients (100%) well tolerated the administration of oral gastrografin. The use of 3D CT enterography significantly improved diagnostic confidence for the interpretation of the level, cause of SBO, and the assessment of the interpretability of each image as compared with the use of axial CT images (P < 0.05). 3D CT enterography was superior as compared to fluoroscopic examination (P < 0.05). CONCLUSION: The use of gastrografin for 3D CT enterography is a safe and feasible technique for precise evaluation of known or suspected SBO.
Authors: Gokce Engudar; Henrik Schaarup-Jensen; Frederikke P Fliedner; Anders E Hansen; Paul Kempen; Rasmus I Jølck; Andreas Kjæer; Thomas L Andresen; Mads H Clausen; Andreas I Jensen; Jonas R Henriksen Journal: Theranostics Date: 2018-11-12 Impact factor: 11.556
Authors: Rudolf Glueckert; Lejo Johnson Chacko; Dominik Schmidbauer; Thomas Potrusil; Elisabeth J Pechriggl; Romed Hoermann; Erich Brenner; Alen Reka; Anneliese Schrott-Fischer; Stephan Handschuh Journal: Front Neurosci Date: 2018-07-31 Impact factor: 4.677